REGN — REGENERON PHARMACEUTICALS

Ownership history in Caption Management, LLC  ·  24 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in REGENERON PHARMACEUTICALS (REGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.72% (2020 Q1)
Avg. % of fund
0.21%
First filed
2019 Q2
Last filed
2025 Q3
Quarters held
24
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 10,000 -20,000 -66.7% 0.04% $5.6M $560.89
2025 Q3 REDUCED 30,000 -1,200 -3.8% 0.13% $16.9M $560.89
2025 Q2 REDUCED 31,200 -28,800 -48.0% 0.18% $16.4M $522.92
2025 Q2 ADDED 60,000 +59,100 +6566.7% 0.35% $31.5M $522.92
20 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    REGN price (monthly, adj. close)

Other funds also holding REGN

As of 2025 Q4 — sorted by position size

Bronte Capital Management Pty Ltd. 3Y 7Y 13.61% Catawba River Capital 3Y 10.08% MCDONALD CAPITAL INVESTORS INC/CA 3Y 7Y 9.86% RK Asset Management, LLC 3Y 7Y 9.22% Orion Investment Co 7.25% SOUTHEASTERN ASSET MANAGEMENT INC/TN/ 3Y 7Y 5.7% GuoLine Advisory Pte Ltd 4.78% Bronte Capital Management Pty Ltd. 3Y 7Y 4.57% Rhenman & Partners Asset Management AB 3Y 7Y 4.43% SOUND SHORE MANAGEMENT INC /CT/ 3Y 7Y 4.32%
← Back to Caption Management, LLC Holdings